Tagged with ONS

Switzerland EY’s Biotech Team Leader for the EMEIA region discusses the challenges Europe’s fragmented capital markets pose for biotech startups, the under-communicated benefits of doing an IPO on the Swiss stock exchange and the implications of the Actelion acquisition for the wider Swiss life sciences ecosystem. Among other things, you are…

Switzerland Patient-driven drug pricing, the uncertain future of Switzerland’s tax regime, and new business models for life science innovators in a changing global market are just a few of the topics touched upon by KPMG Switzerland’s head of life sciences Martin Rohrbach. On February 12th the Swiss people rejected the Tax…

Mexico The founder and managing partner of the LatAm-based consultancy Oriundo, Paul Doulton discusses the company’s unique value offering—comprising both industry veterans and global associates to propel business development—while highlighting Mexico as the frontrunner in region’s pharma market, especially with programs like “doc-in-a-box” trailblazing patient access to healthcare. Having such a…

Singapore According to A.T. Kearney Health Practice Partner Keith Lostaglio, Southeast Asia presents a significant growth opportunity to the pharma industry, and companies which develop effective digital platforms first will gain a significant competitive advantage in the coming years. Singapore’s unique economic role is rooted in openness and globalization. With that…

Ireland Aidan Meagher, Tax Partner & Irish Life Sciences Lead for EY Ireland, discusses EY’s extensive consulting work, including their efforts to promote entrepreneurship in Ireland, the changing landscape facing the medtech industry in the country as well as how Ireland can work to make itself an even more attractive destination…

Philippines Ravinder S. Singha, the Managing Director of Firmlink Pharma, discusses the unique business model they offer to their clients, their key success factors in entering new and sometimes challenging markets, as well as his views on the potential seen in many of the dynamic pharma markets around the world. He…

Philippines Jingle Garcia Diola, Executive Director at Firmlink Pharma, details the company’s value-added services and how they are positioning themselves as the business development partner of choice for large local and multinational companies looking to penetrate new markets. She also discusses her extensive career in the pharmaceutical industry as well as…

Ireland Dan McAlister and Ramy Michael, two of EIDA Solutions’ cofounders, tell us the exciting story behind EIDA Solutions’ rapid growth to become one of the best intelligent construction software companies for the pharmaceutical industry in Ireland, the key features of their software and their plans for internationalization to make EIDA…

Slovakia Deloitte Slovakia’s Chairman, Vladimir Masar, talks about the transferability of his financial banking experience to the consultancy sector, the country’s attractiveness to foreign investment and the current state of its healthcare system. Given your extensive experience of the public and private sectors, could you tell our global executive readers about…

Philippines Alvin So, Bayer Consumer Health Country Division Head, discusses Bayer’s commitment in Consumer Health in the Philippines. He also discusses his vision for the future, including expanding the product portfolio in the country and continuing to be the partner of choice for the Filipino population. When you assumed the position…

Mexico Jorge Romero Castañeda and María Eugenia Mendez, Healthcare & Life Science leader and Strategy & Operations Director at Deloitte respectively, share their expertise about the Healthcare & Life Science sector in Mexico and showcase the integral solutions that the firm offers to the industry to help companies gain competitiveness as…

Singapore HGP Partner and Director of Asia, Ming Chua on the company’s reasons for using Singapore as the first point of entry into Asia, while highlighting the expansion of the country’s biomedical sciences sector as a major factor in HGP’s consistent year-on-year growth. He also speaks to the company’s qualities in…